Endocyte (ECYT)

14.38 +0.12  +0.84%  May 17, 8:00PM
Add to Watchlists Create an Alert

Endocyte Price / Sales Ratio TTM:

10.49 for May 17, 2013
View Full Chart

Endocyte Price / Sales Ratio TTM Chart

    Endocyte Historical Price / Sales Ratio TTM Data

    Pro Data Export
    Dates:  to
    Viewing 1 of 7   First  Previous First    Next  Last   Last

    There is no data for the selected date range.

    Data for this Date Range  
    May 17, 2013 10.49
    May 16, 2013 10.40
    May 15, 2013 10.59
    May 14, 2013 10.59
    May 13, 2013 10.51
    May 10, 2013 10.26
    May 9, 2013 9.783
    May 8, 2013 9.543
    May 7, 2013 9.842
    May 6, 2013 9.813
    May 3, 2013 9.652
    May 2, 2013 10.02
    May 1, 2013 9.886
    April 30, 2013 10.13
    April 29, 2013 10.29
    April 26, 2013 10.31
    April 25, 2013 10.43
    April 24, 2013 10.23
    April 23, 2013 10.26
    April 22, 2013 10.21
    April 19, 2013 10.21
    April 18, 2013 9.696
    April 17, 2013 9.864
    April 16, 2013 10.10
    April 15, 2013 9.572
       
    April 12, 2013 10.28
    April 11, 2013 10.25
    April 10, 2013 10.12
    April 9, 2013 10.16
    April 8, 2013 9.805
    April 5, 2013 9.630
    April 4, 2013 9.856
    April 3, 2013 9.528
    April 2, 2013 9.616
    April 1, 2013 9.032
    March 28, 2013 12.87
    March 27, 2013 12.36
    March 26, 2013 11.11
    March 25, 2013 10.96
    March 22, 2013 10.37
    March 21, 2013 10.16
    March 20, 2013 10.02
    March 19, 2013 9.771
    March 18, 2013 9.843
    March 15, 2013 10.16
    March 14, 2013 9.884
    March 13, 2013 9.574
    March 12, 2013 9.802
    March 11, 2013 9.791
    March 8, 2013 9.822

    About Price to Sales Ratio

    The price to sales ratio (PS ratio) is calculated by dividing stock price by the revenue per share. It is most useful for comparing companies within a sector or industry because "normal" values for this ratio vary from industry to industry. In general, low price to sales ratios are more appealing because they suggest that a company is undervalued.

    An example illustrating why PS ratios should not be compared across industries: On June 21, 2010, Starbucks had a PS ratio of 1.12 while Yahoo! had a PS ratio of 2.56. In other words, Yahoo! shareholders were paying $2.56 for $1 of sales while Starbucks shareholders would only pay $1.12 for $1 of sales. However, at that same moment, the two companies' price to earnings ratios were virtually identical (Starbucks: 28.09 and Yahoo!: 27.78). Hence, shareholders were paying nearly the same amount for $1.00 in earnings. The PS ratios, though, are less comparable since Yahoo!'s profit margins are much higher than that of Starbucks.
    Learn More

    Get data for

    ECYT Price / Sales Ratio TTM Benchmarks

    Companies
    Catalyst Pharmaceutical Partners
    Rigel Pharmaceuticals 157.93
    Sagent Pharmaceuticals 2.233

    ECYT Price / Sales Ratio TTM Rankings

    Overall 46th percentile
    4275 of 8002
    Sector 42nd percentile
    374 of 650 in Healthcare
    Industry 44th percentile
    36 of 65 in Drug Manufacturers - Specialty & Generic

    ECYT Price / Sales Ratio TTM Range, Past 5 Years

    Minimum 9.032 Apr 1 2013
    Maximum 1472.28 Jun 27 2012
    Average 335.38